Portfolio Update

RNS Number : 4660P

Intl. Biotechnology Trust PLC

17 November 2016

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

Portfolio Update as at 31 October 2016

Net Assets	£217m
Net Assets per share	577p
Share price	535p
Total value of unquoted investments	£31m
Total number of portfolio companies	77

Top Ten Holdings

Company Name	% NAV
Celgene	7.0
Biogen	6.7
Incyte	6.6
Regeneron	5.7
Gilead	4.9
Tesaro	4.3
Genmab	4.3
Alexion	4.0
Actelion	3.4
Entellus	3.1
	-----------
Total	50.0

Geographical Allocation	% NAV
US & Canada	80
Europe & UK	20
	-----------
Total	100

Quoted/Unquoted Allocation	% NAV
Quoted	86
Unquoted	14
	-----------
Total	100

NAV % Market Cap	% NAV
Large Cap >USD10BN	52
Mid Cap =USD1-10BN	24
Small Cap <USD1BN	24
	-----------
Total	100

NAV % by Therapeutic Areas	% NAV
Oncology	36
Orphan	16
Inflammation	10
Ophthalmology	7
CNS	6
Medtech	4
Other	21
	-----------
Total	100

BNP Paribas Secretarial Services Limited

Company Secretary

17 NOVEMBER 2016

 

END

 

 

PFUBGBDBGBBBGLR